FDA 483 - ENDOMAGNETICS LTD - May 17, 2018

An FDA inspection of ENDOMAGNETICS LTD, a medical device manufacturer in Cambridge, United Kingdom, identified deficiencies in their quality system. The firm failed to adequately document verification actions for corrective and preventive actions (CAPA). This indicates a lack of robust control over the effectiveness of their corrective measures.